Skip to Content

APO 027 (Ticlopidine 250 mg)

Pill imprint APO 027 has been identified as Ticlopidine hydrochloride 250 mg.

Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ticlopidine hydrochloride 250 mg APO 027
Discount Card Promo
Ticlopidine hydrochloride
Imprint:
APO 027
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0027
Inactive Ingredients:
croscarmellose sodium
microcrystalline cellulose
stearic acid
hypromellose 2910 (5 mPa.s)
polyethylene glycol
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60429-0764 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide